A Phase 2/3, Randomized, Double Blind, Placebo-Controlled, Multicenter Study of NKTR-255 Vs Placebo Following CD-19 Directed CAR-T Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Autor: Perales, Miguel-Angel, Ahmed, Sairah, Dahiya, Saurabh, Riedell, Peter A., McGuirk, Joseph P., Oluwole, Olalekan O., Chaudhry, Sohail A. *, Lee, Zachary *, Dai, Stanley *, Dixit, Neha *, Fanton, Christie *, Marcondes, Mario Q., Zalevsky, Jonathan *, Tagliaferri, Mary A. *, Turtle, Cameron J.
Zdroj: In Blood 15 November 2022 140 Supplement 1:7488-7490
Databáze: ScienceDirect